Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Unearned Common Stock held by the ESOP Cumulative Effect, Period of Adoption, Adjusted Balance	Unearned Common Stock held by the ESOP	Retained Earnings Cumulative effect of change in accounting principle	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Accumulated Other Comprehensive Loss Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Loss	Cumulative effect of change in accounting principle	Cumulative Effect, Period of Adoption, Adjusted Balance	Total
Balance at Dec. 31, 2021		$ 113		$ 46,573		$ (3,709)			$ 89,627		$ (6,635)			$ 125,969
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income									6,997					6,997
Other comprehensive income (loss)											(25,554)			(25,554)	[1]
ESOP shares committed to be allocated				(2)		218								216
Share-based compensation expense				615										615
Share redemption for tax withholding on restricted stock vesting				(111)										(111)
Balance at Dec. 31, 2022	$ 113	113	$ 47,075	47,075	$ (3,491)	(3,491)	$ (633)	$ 95,991	96,624	$ (32,189)	(32,189)	$ (633)	$ 107,499	108,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income									4,395					4,395
Other comprehensive income (loss)											2,691			2,691	[1]
ESOP shares committed to be allocated				(56)		218								162
Share-based compensation expense				396										396
Repurchase of common stock		(2)		(1,378)										(1,380)
Share redemption for tax withholding on restricted stock vesting				(78)										(78)
Balance at Dec. 31, 2023		$ 111		$ 45,959		$ (3,273)			$ 100,386		$ (29,498)			$ 113,685

[1] For additional details related to other comprehensive loss see Note 15, “Accumulated Other Comprehensive Loss.”